Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017

  • ID: 4429110
  • Report
  • 90 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Annulon
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • HighLife SAS
  • Medtronic plc
  • MitrAssist Ltd.
  • MORE
Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Transcatheter Mitral Valves (TMVI) - Medical Devices Pipeline Assessment, 2017" provides an overview of Transcatheter Mitral Valves (TMVI) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transcatheter Mitral Valves (TMVI) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Mitral Valves (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valves (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valves (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Annulon
  • Daidalos Solutions BV
  • Edwards Lifesciences Corp
  • HighLife SAS
  • Medtronic plc
  • MitrAssist Ltd.
  • MORE
1 Table of Contents

2 Introduction
2.1 Transcatheter Mitral Valves (TMVI) Overview

3 Products under Development
3.1 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development
3.2 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory
3.3 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path
3.4 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date
3.5 Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials

4 Transcatheter Mitral Valves (TMVI) - Pipeline Products under Development by Companies
4.1 Transcatheter Mitral Valves (TMVI) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development

5 Transcatheter Mitral Valves (TMVI) Companies and Product Overview
5.1 4C Medical Technologies Inc Company Overview
5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Annulon Company Overview
5.2.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
5.3 Celyad SA Company Overview
5.3.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cephea Valve Technologies, Inc. Company Overview
5.4.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Daidalos Solutions BV Company Overview
5.5.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
5.6 Direct Flow Medical Inc Company Overview
5.6.1 Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Edwards Lifesciences Corp Company Overview
5.7.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.8 Emory University Company Overview
5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.9 HighLife SAS Company Overview
5.9.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
5.10 LivaNova PLC Company Overview
5.10.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medtronic plc Company Overview
5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Micro Interventional Devices, Inc. Company Overview
5.12.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.13 Mitralix Ltd. Company Overview
5.13.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.14 MitrAssist Ltd. Company Overview
5.14.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.15 MValve Technologies Ltd. Company Overview
5.15.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.16 NaviGate Cardiac Structures, Inc. Company Overview
5.16.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.17 Neovasc Inc Company Overview
5.17.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Sino Medical Sciences Technology Inc Company Overview
5.18.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Trinity College Dublin Company Overview
5.19.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.20 University College London Company Overview
5.20.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Valtech Cardio Ltd Company Overview
5.21.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.22 Venus MedTech Company Overview
5.22.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview

6 Transcatheter Mitral Valves (TMVI)- Recent Developments
6.1 Oct 24, 2017: 4C Medicals Novel Mitral Regurgitation Therapy to be Presented at TCT 2017 Shark Tank Innovation Competition
6.2 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.3 Oct 23, 2017: First Patient Treated in Landmark Transcatheter Mitral Valve Replacement Pivotal Trial
6.4 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
6.5 Sep 12, 2017: Neovasc Provides Tiara Clinical Update
6.6 Sep 01, 2017: Decision from Appeals Court upholds lower court decisions but denies injunction
6.7 Aug 22, 2017: Medtronic Reports First Quarter Financial Results
6.8 Aug 03, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit
6.9 Jun 16, 2017: Neovasc Announces German Court Ruling
6.10 Jun 15, 2017: Neovasc Tiara Featured in TVT 2017 Presentation
6.11 Jun 15, 2017: 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum
6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
6.13 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results
6.14 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
6.15 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
6.16 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results
6.17 Jan 19, 2017: LHSC First in Ontario to Implant Canadian made Mitral Valve Device
6.18 Dec 23, 2016: Neovasc Announces Update in Litigation with CardiAQ
6.19 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.20 Dec 06, 2016: Neovasc Provides Update On Its Tiara Mitral Valve Clinical Program
6.21 Nov 28, 2016: Neovasc Receives Regulatory Approval To Initiate TIARA II CE Mark Study
6.22 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results
6.23 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report
6.24 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory
Table 3: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials
Table 6: Transcatheter Mitral Valves (TMVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development
Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: TMVR Implant - Product Status
Table 10: TMVR Implant - Product Description
Table 11: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Mitral Valve Replacement Device - Product Status
Table 13: Mitral Valve Replacement Device - Product Description
Table 14: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Mitral Valve Neo-chordae - Product Status
Table 16: Mitral Valve Neo-chordae - Product Description
Table 17: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Mitral Valve Replacement Device - Product Status
Table 19: Mitral Valve Replacement Device - Product Description
Table 20: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
Table 22: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
Table 23: Direct Flow Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Direct Flow Medical Transcatheter Mitral Valve - Product Status
Table 25: Direct Flow Medical Transcatheter Mitral Valve - Product Description
Table 26: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Cardiaq Mitral Valve - Product Status
Table 28: Cardiaq Mitral Valve - Product Description
Table 29: FORTIS Mitral Transcatheter Heart Valve - Product Status
Table 30: FORTIS Mitral Transcatheter Heart Valve - Product Description
Table 31: PASCAL Transcatheter Mitral Valve Repair System - Product Status
Table 32: PASCAL Transcatheter Mitral Valve Repair System - Product Description
Table 33: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Status
Table 34: Sapien 3 Heart Valve - Mitral Annular Calcification - Product Description
Table 35: Second Generation Transapical Transcatheter Mitral Valve - Product Status
Table 36: Second Generation Transapical Transcatheter Mitral Valve - Product Description
Table 37: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 38: FORTIS Mitral Transcatheter Heart Valve - Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) For the Treatment of Moderate to Severe Mitral Regurgitation
Table 39: Cardiaq Mitral Valve - Early Feasibility Study of the CardiAQ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) For the Treatment of Moderate to Severe Mitral Regurgitation
Table 40: Cardiaq Mitral Valve - Reduction or elimination of Mitral Regurgitation in Degenerative or Functional Mitral Regurgitation with the CardiAQ-Edwards Transcatheter Mitral Valve: The RELIEF Trial
Table 41: Sapien 3 Heart Valve - Mitral Annular Calcification - Surgical Implantation of Transcatheter valve in Native Mitral Annular Calcification (SITRAL) Study
Table 42: Sapien 3 Heart Valve - Mitral Annular Calcification - The Safety and Feasibility of the SAPIEN XT Transcatheter Heart Valve with NovaFlex and Ascendra Delivery Systems and SAPIEN 3 with Commander Delivery System in Patients with Symptomatic Severe Calcific Mitral Valve Disease with Severe Mitral Annular Calcification and Patients with Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Table 43: PASCAL Transcatheter Mitral Valve Repair System - CE Mark Study of PASCAL Transcatheter Mitral Valve Repair System
Table 44: PASCAL Transcatheter Mitral Valve Repair System - The CLASP Study Edwards PASCAL TranScatheter Mitral Valve Repair System Study
Table 45: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 46: MitraCath - Product Status
Table 47: MitraCath - Product Description
Table 48: HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Transcatheter Mitral Valve Replacement System - Product Status
Table 50: Transcatheter Mitral Valve Replacement System - Product Description
Table 51: HighLife SAS - Ongoing Clinical Trials Overview
Table 52: Transcatheter Mitral Valve Replacement System - HighLife Transcatheter Mitral Valve Replacement System for Severe Mitral Regurgitation in Patients at High Surgical Risk
Table 53: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Caisson TMVR System - Product Status
Table 55: Caisson TMVR System - Product Description
Table 56: LivaNova PLC - Ongoing Clinical Trials Overview
Table 57: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE)
Table 58: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Intrepid Transcatheter Mitral Valve Replacement - Product Status
Table 60: Intrepid Transcatheter Mitral Valve Replacement - Product Description
Table 61: TCV - Mitral - Product Status
Table 62: TCV - Mitral - Product Description
Table 63: Twelve Transcatheter Mitral Valve Replacement System - Product Status
Table 64: Twelve Transcatheter Mitral Valve Replacement System - Product Description
Table 65: Medtronic plc - Ongoing Clinical Trials Overview
Table 66: Twelve Transcatheter Mitral Valve Replacement System - Evaluation of Safety and Performance of the Twelve Transcatheter Mitral Valve Replacement System in Patients with Severe, Symptomatic Mitral Regurgitation
Table 67: Intrepid Transcatheter Mitral Valve Replacement - Evaluation of Safety and Efficacy of the Intrepid TMVR System in Patients with Severe, Symptomatic Mitral Valve Regurgitation: APOLLO Trial
Table 68: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 69: Endovalve - Product Status
Table 70: Endovalve - Product Description
Table 71: Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 72: MAESTRO - Product Status
Table 73: MAESTRO - Product Description
Table 74: MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 75: MitrAssist Valve - Product Status
Table 76: MitrAssist Valve - Product Description
Table 77: MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 78: MValve Docking System - Product Status
Table 79: MValve Docking System - Product Description
Table 80: MValve Technologies Ltd. - Ongoing Clinical Trials Overview
Table 81: MValve Docking System - Mitral Valve Replacement with the MValve Dock and a Percutaneous Transcatheter Heart Valve
Table 82: NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Navi Mitral Valved Stent - Product Status
Table 84: Navi Mitral Valved Stent - Product Description
Table 85: NaviGate Cardiac Structures, Inc. - Ongoing Clinical Trials Overview
Table 86: Navi Mitral Valved Stent - Navi Valved Stent for Correction of Severe Functional Mitral Regurgitation (FMR)
Table 87: Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Tiara Transcatheter Mitral Valve - Product Status
Table 89: Tiara Transcatheter Mitral Valve - Product Description
Table 90: Neovasc Inc - Ongoing Clinical Trials Overview
Table 91: Tiara Transcatheter Mitral Valve - Early Feasibility Study of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System
Table 92: Tiara Transcatheter Mitral Valve - Tiara Transcatheter Mitral Valve Replacement Study: TIARA-II
Table 93: Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 94: AccuFit Transapical Mitral Valve Replacement Device - Product Status
Table 95: AccuFit Transapical Mitral Valve Replacement Device - Product Description
Table 96: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 97: MiVaR Device - Product Status
Table 98: MiVaR Device - Product Description
Table 99: University College London Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Percutaneous Mitral Valve Device - Product Status
Table 101: Percutaneous Mitral Valve Device - Product Description
Table 102: Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Valtech Cardiovalve - Product Status
Table 104: Valtech Cardiovalve - Product Description
Table 105: Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Tresillo System - Product Status
Table 107: Tresillo System - Product Description
Table 108: Glossary

List of Figures
Figure 1: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Territory
Figure 3: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Mitral Valves (TMVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Mitral Valves (TMVI) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 4C Medical Technologies Inc
  • Annulon
  • Celyad SA
  • Cephea Valve Technologies, Inc.
  • Daidalos Solutions BV
  • Direct Flow Medical Inc
  • Edwards Lifesciences Corp
  • Emory University
  • HighLife SAS
  • LivaNova PLC
  • Medtronic plc
  • Micro Interventional Devices, Inc.
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • Sino Medical Sciences Technology Inc
  • Trinity College Dublin
  • University College London
  • Valtech Cardio Ltd
  • Venus MedTech
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll